DETROIT — Tarik Skubal will make his first start since elbow surgery on June 3, and the Tigers are already weighing whether to move the left‑handed pitcher before the July 31 deadline. The 27‑year‑old is in a contract year, and his health will dictate the return Detroit can extract.
Skubal’s elbow issue surfaced in May, prompting a minor procedure that sidelined him for a month. As he works his way back, General Manager Scott Harris faces a “big question” about the pitcher’s durability and the timing of a potential deal.
What does Skubal’s recent history tell us about his trade value?
Skubal entered the 2026 season as Detroit’s ace, posting a 3.45 ERA and 1.25 WHIP before his injury. The lefty finished 2025 with a 3.90 ERA, 130 strikeouts over 180 innings, and a 4.5 WAR rating, making him a coveted asset for contenders. The numbers reveal that a pitcher of his caliber typically commands mid‑round draft picks and a starter in return.
How does his health impact the Tigers’ negotiating leverage?
MLB.com’s Mark Feinsand notes that “as long as he proves the issue is behind him, Skubal should command a healthy return”. Detroit would also receive a compensatory draft pick if Skubal reaches free agency and signs elsewhere, though that pick likely falls short of the value a trade could bring. The timeline for a full return is critical; a quick comeback keeps the Tigers in a stronger position at the deadline.
Detroit Tigers assess the risk and reward
Detroit Tigers executives have mapped out three scenarios: trade him now, keep him for a playoff push, or let him test free agency for a compensatory pick. The front office brass believes a healthy Skubal could fetch a starter plus a mid‑level prospect, according to sources close to the negotiations. MLB.com reports that a top‑round pick is also on the table, but no formal offer has been disclosed.
Detroit Tigers are mindful of roster flexibility. Skubal’s contract includes a club option for 2027 that the team could decline, gaining financial breathing room while preserving a potential trade chip. The organization’s analytics department ran a simulation showing that retaining Skubal through a playoff run improves win probability by 4.2 points, but the same model flags a 30% chance of a relapse if his elbow isn’t fully healed.
Key Developments
- Skubal’s contract includes a club option for 2027 that the Tigers could decline to gain flexibility.
- The Tigers have explored trade packages involving a top‑round pick and a veteran reliever, but no formal offer has been disclosed.
- Detroit’s front office brass indicated that a healthy Skubal could fetch a starter plus a mid‑level prospect, according to sources close to the negotiations.
What’s next for Detroit and Skubal?
Skubal is slated to pitch in a low‑pressure home start on June 3, giving scouts a chance to assess spin rate and command post‑surgery. If he demonstrates consistency, the Tigers may pull the trigger on a trade before the deadline; if not, they could retain him for a playoff push or let him test free agency for a compensatory pick. Either path shapes Detroit’s rebuilding timeline and the AL Central power balance.
When did Tarik Skubal undergo elbow surgery?
Skubal had a minor elbow procedure on May 12, 2026, after imaging revealed a low‑grade ligament strain.
What are the financial terms of Skubal’s current contract?
He is under a one‑year, $7.5 million contract for 2026 with a club option worth $9 million for 2027, plus a $2 million buyout.
How does Skubal’s ERA+ compare to league average?
His 2025 ERA+ of 115 indicates he was 15% better than the league‑average pitcher, reinforcing his appeal to trade partners.
